Biocryst Pharmaceuticals stockBCRX
Biocryst Pharmaceuticals trades at $7.63, 32.0% below its 52-week high (Jul 9, 2026). The price is below its 50- and 200-day averages, a downtrend. −2.2% year to date, +6.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 24, 2027.
Ratings, candles, signals and the screener for BCRX — after you log in
Open the terminalFrequently asked questions about Biocryst Pharmaceuticals
What is the Biocryst Pharmaceuticals stock price?
At the close on Nov 5, 2026: $7.63 (−7.40% on the day). 52-week high: $11.22 on Jul 9, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Biocryst Pharmaceuticals report earnings?
The next quarterly report is on Feb 24, 2027. Last quarter, earnings per share changed +133% year over year, revenue +13%.
Does Biocryst Pharmaceuticals pay dividends?
No, Biocryst Pharmaceuticals does not pay dividends.
Where does Biocryst Pharmaceuticals trade and how to buy it?
Ticker BCRX, exchange Nasdaq, listed since 1994. You can buy it through a broker with access to US exchanges.
Should I buy Biocryst Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BCRX are in the terminal after you log in.